{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:02:54Z","timestamp":1793012574520,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s13760-020-01473-5","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T08:03:58Z","timestamp":1597824238000},"page":"1297-1305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Genetics of Parkinson's disease"],"prefix":"10.1007","volume":"120","author":[{"given":"Ajith","family":"Cherian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4695-8842","authenticated-orcid":false,"given":"K. P.","family":"Divya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"issue":"5","key":"1473_CR1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K et al (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384\u2013386","journal-title":"Neurology"},{"issue":"6","key":"1473_CR2","first-page":"525","volume":"5","author":"LML de Lau","year":"2006","unstructured":"de Lau LML, Breteler MMB (2006) Epidemiology of Parkinson's disease. LancetNeurol 5(6):525\u2013535","journal-title":"LancetNeurol"},{"key":"1473_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70287-X","author":"A Schrag","year":"2015","unstructured":"Schrag A, Horsfall L, Walters K, Noyce A, Petersen I (2015) Prediagnostic presentations of Parkinson's disease in primary care: a case-control study. Lancet. https:\/\/doi.org\/10.1016\/S1474-4422(14)70287-X","journal-title":"Lancet"},{"issue":"9","key":"1473_CR4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/jnnp-2015-312283","volume":"87","author":"F Moisan","year":"2016","unstructured":"Moisan F, Kab S, Mohamed F, Canonico M, Le Guern M, Quintin C, Carcaillon L, Nicolau J, Duport N, Singh-Manoux A, Boussac-Zarebska M, Elbaz A (2016) Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J Neurol Neurosurg Psychiatry 87(9):952\u2013957","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1473_CR5","doi-asserted-by":"crossref","first-page":"839e840","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839e840","journal-title":"Nature"},{"issue":"6","key":"1473_CR6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"H-C Cheng","year":"2010","unstructured":"Cheng H-C, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67(6):715\u2013725","journal-title":"Ann Neurol"},{"issue":"1","key":"1473_CR7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson's disease. Mov Disord 28(1):24\u201330","journal-title":"Mov Disord"},{"issue":"5","key":"1473_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O","volume":"45","author":"P Piccini","year":"1999","unstructured":"Piccini P, Burn DJ, Ceravolo R, Maraganore D, Brooks DJ (1999) The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 45(5):577\u2013582","journal-title":"Ann Neurol"},{"issue":"10","key":"1473_CR9","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.neurobiolaging.2011.02.017","volume":"32","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt K, Margaret G, Reynolds CA, Prescott CA, Pedersen NL (2011) Heritability of Parkinson disease in Swedish twins: a longitudinal study. Neurobiol Aging. 32(10):1923\u20131923","journal-title":"Neurobiol Aging."},{"issue":"7","key":"1473_CR10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7150\/ijbs.3.420","volume":"3","author":"M Zhu","year":"2007","unstructured":"Zhu M, Zhao S (2007) Candidate Gene Identification Approach: Progress and Challenges. Int J Biol Sci 3(7):420\u2013427","journal-title":"Int J Biol Sci"},{"key":"1473_CR11","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1093\/hmg\/dds335","volume":"21","author":"MF Keller","year":"2012","unstructured":"Keller MF, Saad M, Bras J, Bettella F, Nicolaou N, Simon-Sanchez J et al (2012) Using genome-wide complex trait analysis to quantify \u2018missing heritability\u2019 in Parkinson\u2019s disease. Hum Mol Genet 21:4996\u20135009","journal-title":"Hum Mol Genet"},{"key":"1473_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrg2626","volume":"11","author":"ML Metzker","year":"2010","unstructured":"Metzker ML (2010) Sequencing technologies \u2013 the next generation. Nat Rev Genet 11:31\u201346","journal-title":"Nat Rev Genet"},{"key":"1473_CR13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ejhg.2011.258","volume":"20","author":"C Gilissen","year":"2012","unstructured":"Gilissen C, Hoischen A, Brunner HG, Veltman JA (2012) Disease gene identification strategies for exome sequencing. Eur J Hum Genet 20:490\u2013497","journal-title":"Eur J Hum Genet"},{"key":"1473_CR14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","volume":"274","author":"MH Polymeropoulos","year":"1996","unstructured":"Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA et al (1996) Mapping of a gene for Parkinson\u2019s disease to chromosome 4q21-q23. Science 274:1197\u20131199","journal-title":"Science"},{"key":"1473_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.25373","volume":"28","author":"BP OlanowCW","year":"2013","unstructured":"OlanowCW BP (2013) Parkinson\u2019s disease and alpha synuclein: is Parkinson\u2019s disease a prion-like disorder? Mov Disord 28:31\u201340","journal-title":"Mov Disord"},{"key":"1473_CR16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0304-3940(02)01178-3","volume":"336","author":"EK Tan","year":"2003","unstructured":"Tan EK, Tan C, Shen H, Chai A, Lum SY, Teoh ML, Yih Y, Wong MC, Zhao Y (2003) Alpha synuclein promoter and risk of Parkinson's disease microsatellite and allelic size variability. Neurosci Lett 336:70","journal-title":"Neurosci Lett"},{"key":"1473_CR17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","volume":"125","author":"AP Kiely","year":"2013","unstructured":"Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P et al (2013) alpha-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy? Acta Neuropathol 125:753\u2013769","journal-title":"Acta Neuropathol"},{"issue":"5321","key":"1473_CR18","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"11","key":"1473_CR19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.parkreldis.2013.07.011","volume":"19","author":"D Hoffman-Zacharska","year":"2013","unstructured":"Hoffman-Zacharska D, Koziorowski D, Ross OA et al (2013) Novel A18T and pA29S substitutions in \u03b1-synuclein may be associated with sporadic Parkinson's disease. Parkinsonism Related Dis 19(11):1057\u20131060","journal-title":"Parkinsonism Related Dis"},{"issue":"9440","key":"1473_CR20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"M Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin M, Kachergus J, Roumier C et al (2004) \u03b1-synuclein locus duplication as a cause of familial Parkinson's disease. The Lancet 364(9440):1167\u20131169","journal-title":"The Lancet"},{"issue":"6","key":"1473_CR21","doi-asserted-by":"crossref","first-page":"a024109","DOI":"10.1101\/cshperspect.a024109","volume":"8","author":"RL Nussbaum","year":"2018","unstructured":"Nussbaum RL (2018) Genetics of Synucleinopathies. Cold Spring Harb Perspect Med 8(6):a024109","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1\u20133","key":"1473_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbamcr.2003.08.008","volume":"1643","author":"LVHP Bosgraaf","year":"2003","unstructured":"Bosgraaf LVHP (2003) Roc, a Ras\/GTPase domain in complex proteins. Biochim Biophys Acta 1643(1\u20133):5\u201310","journal-title":"Biochim Biophys Acta"},{"key":"1473_CR23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","volume":"51","author":"M Funayama","year":"2002","unstructured":"Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F (2002) A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 51:296\u2013301","journal-title":"Ann Neurol"},{"key":"1473_CR24","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/01.WNL.0000125015.06989.DB","volume":"62","author":"ZK Wszolek","year":"2004","unstructured":"Wszolek ZK, Pfeiffer RF, Tsuboi Y, Uitti RJ, McComb RD, Stoessl AJ, Strongosky AJ, Zimprich A, M\u00fcller-Myhsok B, Farrer MJ, Gasser T, Calne DB, Dickson DW (2004) Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 62:1619\u20131622","journal-title":"Neurology"},{"issue":"4","key":"1473_CR25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44(4):601\u2013607","journal-title":"Neuron"},{"issue":"10","key":"1473_CR26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1474-4422(11)70175-2","volume":"10","author":"OA Ross","year":"2011","unstructured":"Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G et al (2011 ) Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 10(10):898\u2013908","journal-title":"Lancet Neurol"},{"issue":"7","key":"1473_CR27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S et al (2008 ) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7(7):583\u2013590","journal-title":"Lancet Neurol"},{"key":"1473_CR28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nn1776","volume":"9","author":"WW Smith","year":"2006","unstructured":"Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9:1231\u20131233","journal-title":"Nat Neurosci"},{"key":"1473_CR29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.2199","volume":"16","author":"BD Lee","year":"2010","unstructured":"Lee BD, Shin J-H, VanKampen J, Petrucelli L, West AB, Ko HS, Lee Y-I, Maguire-Zeiss KA, Bowers WJ, Federoff HJ, Dawson VL, Dawson TM (2010) Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nature Med 16:998\u20131000","journal-title":"Nature Med"},{"issue":"1","key":"1473_CR30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","volume":"89","author":"C Vilari-no-G\u00fcell","year":"2011","unstructured":"Vilari-no-G\u00fcell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ et al (2011) VPS35 mutations in Parkinson disease. Am J Hum Genet 89(1):162\u2013167","journal-title":"Am J Hum Genet"},{"issue":"8","key":"1473_CR31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneurol.2013.132","volume":"9","author":"J Trinh","year":"2013","unstructured":"Trinh J, Farrer M (2013 ) Advances in the genetics of Parkinson disease. Nat Rev Neurol 9(8):445\u2013454","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1473_CR32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","volume":"89","author":"A Zimprich","year":"2011","unstructured":"Zimprich A, Benet-Pages A, Struhal W, Graf E, Eck SH, Offman MN et al (2011) A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 89(1):168\u2013175","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1473_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ane.12397","volume":"132","author":"H Deng","year":"2015","unstructured":"Deng H, Wu Y, Jankovic J (2015) The EIF4G1 gene and Parkinson's disease. Acta Neurol Scand 132(2):73\u201378","journal-title":"Acta Neurol Scand"},{"key":"1473_CR34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajhg.2011.08.009","volume":"89","author":"MC Chartier-Harlin","year":"2011","unstructured":"Chartier-Harlin MC, Dachsel JC, Vilarino-Guell C, Lincoln SJ, Lepretre F, Hulihan MM et al (2011) Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet 89:398\u2013406","journal-title":"Am J Hum Genet"},{"key":"1473_CR35","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361:1651\u20131661","journal-title":"N Engl J Med"},{"issue":"Pt 2","key":"1473_CR36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/brain\/aws318","volume":"136","author":"SE Winder-Rhodes","year":"2013","unstructured":"Winder-Rhodes SE, Evans JR, Ban M, Mason SL, Williams-Gray CH, Foltynie T et al (2013) Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort. Brain 136(Pt 2):392\u2013399","journal-title":"Brain"},{"key":"1473_CR37","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1212\/NXG.0000000000000057","volume":"2","author":"G Lopez","year":"2016","unstructured":"Lopez G, Kim J, Wiggs E, Cintron D, Groden C, Tayebi N et al (2016) Clinical course and prognosis in patients with Gaucher disease and parkinsonism. Neurol Genet 2:e57","journal-title":"Neurol Genet"},{"key":"1473_CR38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/mds.26359","volume":"31","author":"IF Mata","year":"2016","unstructured":"Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM et al (2016) GBA variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Mov Disord 31:95\u2013102","journal-title":"Mov Disord"},{"key":"1473_CR39","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.24777","volume":"80","author":"R Cilia","year":"2016","unstructured":"Cilia R, Tunesi S, Marotta G, Cereda E, Siri C, Tesei S et al (2016) Survival and dementia in GBA-associated Parkinson's disease: the mutation matters. Ann Neurol 80:662\u2013673","journal-title":"Ann Neurol"},{"issue":"8","key":"1473_CR40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/jmedgenet-2015-103616","volume":"53","author":"S Sudhaman","year":"2016","unstructured":"Sudhaman S, Muthane UB, Behari M, Govindappa ST, Juyal RC, Thelma BK (2016) Evidence of mutations in RIC3 acetylcholine receptor chaperone as a novel cause of autosomal-dominant Parkinson's disease with non-motor phenotypes. J Med Genet 53(8):559\u2013566","journal-title":"J Med Genet"},{"issue":"6676","key":"1473_CR41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al (1998) Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605\u2013608","journal-title":"Nature"},{"issue":"5674","key":"1473_CR42","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S et al (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304(5674):1158\u20131160","journal-title":"Science"},{"issue":"5604","key":"1473_CR43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299(5604):256\u2013259","journal-title":"Science"},{"issue":"12","key":"1473_CR44","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/mds.25132","volume":"27","author":"LL Kilarski","year":"2012","unstructured":"Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MDW, Misbahuddin A et al (2012 ) Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. Mov Disord 27(12):1522\u20131529","journal-title":"Mov Disord"},{"key":"1473_CR45","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","volume":"342","author":"CB Lucking","year":"2000","unstructured":"Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW et al (2000) Association between early-onset Parkinson\u2019s disease and mutations in the Parkin gene. French Parkinson\u2019s Disease Genetics Study Group. N Engl J Med 342:1560\u20131567","journal-title":"N Engl J Med"},{"key":"1473_CR46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/WCO.0b013e3281e6692b","volume":"20","author":"C Klein","year":"2007","unstructured":"Klein C, Lohmann-Hedrich K (2007) Impact of recent genetic findings in Parkinson\u2019s disease. Curr Opin Neurol 20:453\u2013464","journal-title":"Curr Opin Neurol"},{"key":"1473_CR47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10048-009-0174-4","volume":"10","author":"C Cazeneuve","year":"2009","unstructured":"Cazeneuve C, San C, Ibrahim SA, Mukhtar MM, Kheir MM, Leguern E, Brice A, Salih MA (2009) A new complex homozygous large rearrangement of the PINK1 gene in a Sudanese family with early onset Parkinson\u2019s disease. Neurogenetics 10:265\u2013270","journal-title":"Neurogenetics"},{"key":"1473_CR48","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mds.22365","volume":"24","author":"ST Camargos","year":"2009","unstructured":"Camargos ST, Dornas LO, Momeni P, Lees A, Hardy J, Singleton A, Cardoso F (2009) Familial Parkinsonism and early onset Parkinson\u2019s disease in a Brazilian movement disorders clinic: Phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations. Mov Disord 24:662\u2013666","journal-title":"Mov Disord"},{"key":"1473_CR49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/humu.9472","volume":"28","author":"R Marongiu","year":"2007","unstructured":"Marongiu R, Brancati F, Antonini A, Ialongo T, Ceccarini C, Scarciolla O, Capalbo A, Benti R, Pezzoli G, Dallapiccola B et al (2007) Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum. Hum Mutat 28:98","journal-title":"Hum Mutat"},{"key":"1473_CR50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm3028","volume":"12","author":"RJ Youle","year":"2011","unstructured":"Youle RJ, Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12:9\u201314","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1473_CR51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neulet.2006.09.003","volume":"408","author":"N Pankratz","year":"2006","unstructured":"Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Wojcieszek J, Rudolph A, Shults CW, Foroud T, Nichols WC (2006) Mutations in DJ-1 are rare in familial Parkinson disease. Neurosci Lett 408:209\u2013213","journal-title":"Neurosci Lett"},{"key":"1473_CR52","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.1073\/pnas.0409635102","volume":"102","author":"E Junn","year":"2005","unstructured":"Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, Mouradian MM (2005) Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci 102:9691\u20139696","journal-title":"Proc Natl Acad Sci"},{"issue":"14","key":"1473_CR53","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","volume":"102","author":"RH Kim","year":"2005","unstructured":"Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S et al (2005 ) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A 102(14):5215\u20135220","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1473_CR54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.24553","volume":"79","author":"S Olgiati","year":"2016","unstructured":"Olgiati S, Quadri M, Fang M, Rood JPMA, Saute JA, Chien HF et al (2016 ) DNAJC6 mutations associated with early-onset Parkinson's disease. Ann Neurol 79(2):244\u2013256","journal-title":"Ann Neurol"},{"issue":"2","key":"1473_CR55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.24591","volume":"79","author":"LEO Elsayed","year":"2016","unstructured":"Elsayed LEO, Drouet V, Usenko T, Mohammed IN, Hamed AAA, Elseed MA et al (2016 ) A novel nonsense mutation in DNAJC6 expands the phenotype of autosomal-recessive juvenile-onset Parkinson's disease. Ann Neurol 79(2):335\u2013337","journal-title":"Ann Neurol"},{"issue":"6","key":"1473_CR56","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1600-0854.2007.00568.x","volume":"8","author":"E Eisenberg","year":"2007","unstructured":"Eisenberg E, Greene LE (2007 ) Multiple roles of auxilin and hsc70 in clathrin-mediated endocytosis. Traffic 8(6):640\u2013646","journal-title":"Traffic"},{"key":"1473_CR57","first-page":"2646","volume":"21","author":"J Bras","year":"2012","unstructured":"Bras J, Verloes A, Schneider SA, Mole SE, Guerreiro RJ (2012) Mutation of the Parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum MolGenet 21:2646\u20132650","journal-title":"Hum MolGenet"},{"key":"1473_CR58","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.neurobiolaging.2010.05.009","volume":"33","author":"C Paisan-Ruiz","year":"2012","unstructured":"Paisan-Ruiz C, Li A, Schneider SA, Holton JL, Johnson R, Kidd D et al (2012) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 33:814\u2013823","journal-title":"Neurobiol Aging"},{"key":"1473_CR59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/NEN.0b013e318293c586","volume":"72","author":"T Zhao","year":"2013","unstructured":"Zhao T, Severijnen LA, van der Weiden M, Zheng PP, Oostra BA, Hukema RK et al (2013) FBXO7 immunoreactivity in alpha-synuclein-containing inclusions in Parkinson disease and multiple system atrophy. J Neuropathol Exp Neurol 72:482\u2013488","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1200\u20137","key":"1473_CR60","first-page":"30","volume":"34","author":"CE Krebs","year":"2013","unstructured":"Krebs CE, Karkheiran S, Powell JC, Cao M, Makarov V, Darvish H et al (2013) The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures. Hum Mutat 34(1200\u20137):30","journal-title":"Hum Mutat"},{"key":"1473_CR61","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/humu.22373","volume":"34","author":"M Quadri","year":"2013","unstructured":"Quadri M, Fang M, Picillo M, Olgiati S, Breedveld GJ, Graafland J et al (2013) Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism. Hum Mutat 34:1208\u20131215","journal-title":"Hum Mutat"},{"issue":"2","key":"1473_CR62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ng1508","volume":"37","author":"H Stefansson","year":"2005","unstructured":"Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, Barnard J et al (2005 ) A common inversion under selection in Europeans. Nat Genet 37(2):129\u2013137","journal-title":"Nat Genet"},{"issue":"18","key":"1473_CR63","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1001\/jama.286.18.2245","volume":"286","author":"ER Martin","year":"2001","unstructured":"Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC et al (2001) Association of single-nucleotide polymorphisms of the tau gene with late onset Parkinson disease. JAMA 286(18):2245\u20132250","journal-title":"JAMA"},{"issue":"3","key":"1473_CR64","doi-asserted-by":"crossref","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","volume":"8","author":"CM Lill","year":"2012","unstructured":"Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide B-MM et al (2012) Comprehensive research synopsis and systematic meta analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet 8(3):e1002548","journal-title":"PLoS Genet"},{"issue":"2","key":"1473_CR65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(19)30394-1","volume":"19","author":"KM Moore","year":"2020","unstructured":"Moore KM, Nicholas J, Grossman M et al (2020) Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 19(2):145\u2013156","journal-title":"Lancet Neurol."},{"issue":"8","key":"1473_CR66","doi-asserted-by":"crossref","first-page":"e1002237","DOI":"10.1371\/journal.pgen.1002237","volume":"7","author":"TH Hamza","year":"2011","unstructured":"Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, Kay DM et al (2011 ) Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet 7(8):e1002237","journal-title":"PLoS Genet"},{"issue":"11","key":"1473_CR67","doi-asserted-by":"crossref","first-page":"e1004788","DOI":"10.1371\/journal.pgen.1004788","volume":"10","author":"I Ahmed","year":"2014","unstructured":"Ahmed I, Lee P-C, Lill CM, Searles Nielsen S, Artaud F, Gallagher LG et al (2014) Lack of replication of the GRIN2A-by-coffee interaction in Parkinson disease. PLoS Genet 10(11):e1004788","journal-title":"PLoS Genet"},{"issue":"6","key":"1473_CR68","first-page":"530e537","volume":"13","author":"EM Hill-Burns","year":"2013","unstructured":"Hill-Burns EM, Singh N, Ganguly P, Hamza TH, Montimurro J, Kay DM et al (2013) A genetic basis for the variable effect of smoking\/nicotine on Parkinson's disease. Pharmacogenomics J 13(6):530e537","journal-title":"Pharmacogenomics J"},{"key":"1473_CR69","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng.3589","volume":"48","author":"H Deng","year":"2016","unstructured":"Deng H, Shi Y, Yang Y et al (2016) Identification of TMEM230 mutations in familial Parkinson's disease. Nat Genet 48:733\u2013739","journal-title":"Nat Genet"},{"key":"1473_CR70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41588-019-0354-6","volume":"51","author":"MJ Farrer","year":"2019","unstructured":"Farrer MJ (2019) Doubts about TMEM230 as a gene for Parkinsonism. Nat Genet 51:367\u2013368","journal-title":"Nat Genet"},{"issue":"7","key":"1473_CR71","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(18)30179-0","volume":"17","author":"M Quadri","year":"2018","unstructured":"Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E, Breedveld GJ et al (2018) LRP10 genetic variants in familial Parkinson\u2019s disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study. Lancet Neurol 17(7):597\u2013608","journal-title":"Lancet Neurol"},{"issue":"6","key":"1473_CR72","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.27693","volume":"34","author":"Y Chen","year":"2019","unstructured":"Chen Y, Cen Z, Zheng X, Pan Q, Chen X, Zhu L, Si C et al (2019) LRP10 in autosomal-dominant Parkinson\u2019s disease. Mov Disord 34(6):912\u2013916","journal-title":"Mov Disord"},{"issue":"45","key":"1473_CR73","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1073\/pnas.1809969115","volume":"115","author":"J-F Guo","year":"2018","unstructured":"Guo J-F, Zhang L, Li K, Mei J-P, Xue J, Chen J, Tang X et al (2018) Coding mutations in contribute to Parkinson\u2019s disease. Proc Natl Acad Sci U S A 115(45):11567\u201311572","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1473_CR74","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz205","author":"JS Lee","year":"2019","unstructured":"Lee JS, Kanai K, Suzuki M, Kim WS, Yoo HS, Yuhong F, Kim D-K et al (2019) Arylsulfatase A, a genetic modifier of Parkinson\u2019s disease, is an \u03b1-synuclein chaperone. Neurol Brain J. https:\/\/doi.org\/10.1093\/brain\/awz205","journal-title":"Neurol Brain J"},{"key":"1473_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz340","author":"MB Makarious","year":"2019","unstructured":"Makarious MB, Diez-Fairen M, Krohn L, Blauwendraat C, Bandres-Ciga S, Ding J, Pihlstr\u00f8m L, Houlden H, Scholz SW, Gan-Or Z (2019) ARSA variants in \u03b1-synucleinopathies. Brain A J Neurol. https:\/\/doi.org\/10.1093\/brain\/awz340","journal-title":"Brain A J Neurol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01473-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01473-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01473-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:42:59Z","timestamp":1629333779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01473-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1473"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01473-5","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}